Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Budesonide + vitamin e is a combination of two agents: budesonide, a synthetic corticosteroid with potent anti-inflammatory properties, and vitamin E (tocopherol), an essential fat-soluble antioxidant. Budesonide acts primarily by binding to the glucocorticoid receptor, leading to suppression of inflammatory gene expression and reduction of cytokine production. It is commonly used for conditions such as Crohn’s disease, ulcerative colitis, asthma, and allergic rhinitis[4][5][7]. Vitamin E functions as an antioxidant that protects cell membranes from oxidative damage by neutralizing free radicals. The combination may be considered in clinical or investigational settings where both anti-inflammatory and antioxidant effects are desired; however, there is no widely approved or marketed fixed-dose product containing both agents together.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on budesonide + vitamin e.